STENDRA
- Product NDC
- 62541-503
- 11-digit product format
- 625410503
- Labeler code
- 62541
- Product ID
- 62541-503_eb531904-a6c1-6aec-e053-2995a90a5835
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Avanafil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Vivus LLC
- Application
- NDA202276
- Marketing category
- NDA
- Marketing start
- 2022-01-01
- Marketing end
- 0000-00-00
- Substance
- AVANAFIL
- Active strength
- 200 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62541-503-30 | 62541050330 | 30 TABLET in 1 BOTTLE (62541-503-30) | 30 tablet | 2022-01-01 | 0000-00-00 | No | No | Current |